138 related articles for article (PubMed ID: 20087647)
1. The association between TA-repeat polymorphism in the promoter region of UGT1A1 and breast cancer risk: a meta-analysis.
Yao L; Qiu LX; Yu L; Yang Z; Yu XJ; Zhong Y; Yu L
Breast Cancer Res Treat; 2010 Aug; 122(3):879-82. PubMed ID: 20087647
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer.
Adegoke OJ; Shu XO; Gao YT; Cai Q; Breyer J; Smith J; Zheng W
Breast Cancer Res Treat; 2004 Jun; 85(3):239-45. PubMed ID: 15111762
[TBL] [Abstract][Full Text] [Related]
3. Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.
Yao L; Yu X; Yu L
Breast Cancer Res Treat; 2010 Jul; 122(2):503-7. PubMed ID: 20052535
[TBL] [Abstract][Full Text] [Related]
4. Promoter length polymorphism in UGT1A1 and the risk of sporadic colorectal cancer.
Bajro MH; Josifovski T; Panovski M; Jankulovski N; Nestorovska AK; Matevska N; Petrusevska N; Dimovski AJ
Cancer Genet; 2012 Apr; 205(4):163-7. PubMed ID: 22559977
[TBL] [Abstract][Full Text] [Related]
5. No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects.
Yao L; Fang F; Wu Q; Zhong Y; Yu L
Breast Cancer Res Treat; 2010 Jul; 122(1):237-42. PubMed ID: 20033481
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms in the UGT1A1 gene and breast cancer risk in Greek women.
Tsezou A; Tzetis M; Giannatou E; Gennatas C; Pampanos A; Kanavakis E; Kitsiou-Tzeli S
Genet Test; 2007; 11(3):303-6. PubMed ID: 17949292
[TBL] [Abstract][Full Text] [Related]
7. Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels.
Guillemette C; De Vivo I; Hankinson SE; Haiman CA; Spiegelman D; Housman DE; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):711-4. PubMed ID: 11401924
[TBL] [Abstract][Full Text] [Related]
8. The association of SULT1A1 codon 213 polymorphism and breast cancer susceptibility: meta-analysis from 16 studies involving 23,445 subjects.
Sun Y; Zang Z; Xu X; Zhang Z; Zhong L; Zan W; Zhao Y; Sun L
Breast Cancer Res Treat; 2011 Jan; 125(1):215-9. PubMed ID: 20505990
[TBL] [Abstract][Full Text] [Related]
9. No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis.
Yu KD; Chen AX; Shao ZM
Breast Cancer Res Treat; 2010 Aug; 122(3):853-8. PubMed ID: 20076999
[TBL] [Abstract][Full Text] [Related]
10. IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls.
Qiu LX; Yao L; Yuan H; Mao C; Chen B; Zhan P; Xue K; Zhang J; Hu XC
Breast Cancer Res Treat; 2010 Aug; 122(3):867-71. PubMed ID: 20084546
[TBL] [Abstract][Full Text] [Related]
11. Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects.
Qiu LX; Yuan H; Yu KD; Mao C; Chen B; Zhan P; Xue K; Zhang J; Hu XC
Breast Cancer Res Treat; 2010 Jun; 121(3):703-8. PubMed ID: 19936916
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and breast cancer risk in Africans.
Huo D; Kim HJ; Adebamowo CA; Ogundiran TO; Akang EE; Campbell O; Adenipekun A; Niu Q; Sveen L; Fackenthal JD; Fackenthal DL; Das S; Cox N; Di Rienzo A; Olopade OI
Breast Cancer Res Treat; 2008 Jul; 110(2):367-76. PubMed ID: 17909964
[TBL] [Abstract][Full Text] [Related]
13. No significant association between the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis of 21 studies involving 24,063 subjects.
Ma Y; Yang J; Liu Z; Zhang P; Yang Z; Wang Y; Qin H
Breast Cancer Res Treat; 2011 Jan; 125(1):201-5. PubMed ID: 20496166
[TBL] [Abstract][Full Text] [Related]
14. The association between IGF1 CA repeat polymorphisms and breast cancer risk: a meta-analysis.
Huang Q; Wang C; Qiu LJ; Shao F; Yu JH
Breast Cancer Res Treat; 2011 Aug; 129(1):191-4. PubMed ID: 21390492
[TBL] [Abstract][Full Text] [Related]
15. Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.
Qiu LX; Yao L; Mao C; Yu KD; Zhan P; Chen B; Yuan H; Zhang J; Xue K; Hu XC
Breast Cancer Res Treat; 2010 Jul; 122(2):521-5. PubMed ID: 20054636
[TBL] [Abstract][Full Text] [Related]
16. TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls.
Gu D; Zhuang L; Huang H; Cao P; Wang D; Tang J; Chen J
Breast Cancer Res Treat; 2010 Oct; 123(3):857-61. PubMed ID: 20157775
[TBL] [Abstract][Full Text] [Related]
17. The association between HSD17B1 Ser312Gly polymorphism and breast cancer risk: a meta-analysis including 31,053 subjects.
Yao L; Cao LH; Qiu LX; Yu L
Breast Cancer Res Treat; 2010 Sep; 123(2):577-80. PubMed ID: 20151320
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study.
Shatalova EG; Walther SE; Favorova OO; Rebbeck TR; Blanchard RL
Breast Cancer Res; 2005; 7(6):R909-21. PubMed ID: 16280036
[TBL] [Abstract][Full Text] [Related]
19. Associations between the SRD5A2 gene V89L and TA repeat polymorphisms and breast cancer risk: a meta-analysis.
Zhang D; Li Q; Qu HC; Yu T; Liu YR
Genet Mol Res; 2015 Aug; 14(3):9004-12. PubMed ID: 26345832
[TBL] [Abstract][Full Text] [Related]
20. [Association of polymorphisms in SULT1A1 and UGT1A1 Genes with breast cancer risk and phenotypes in Russian women].
Shatalova EG; Loginov VI; Braga EA; Kazubskaia TP; Sudomoina MA; Blanchard RL; Favorova OO
Mol Biol (Mosk); 2006; 40(2):263-70. PubMed ID: 16637266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
